The nasal microbiome represents a complex and dynamic microbial ecosystem that contributes to mucosal defense, epithelial homeostasis, immune regulation, and olfactory function. Increasing evidence indicates that this microbial community actively interacts with host physiology, while alterations in its composition are associated with chronic inflammation, oxidative stress, and olfactory impairment. Such changes have been reported in conditions including chronic rhinosinusitis, allergic rhinitis, and post-viral anosmia. Beyond local effects, chronic nasal inflammation has been hypothesized to influence neuroinflammatory processes and protein aggregation pathways involving α-synuclein and tau, potentially linking nasal microbial imbalance to neurodegenerative mechanisms. However, current evidence remains largely indirect and does not support a causal relationship. This narrative review summarizes current clinical and immunological evidence on the role of the nasal microbiome in olfactory function and dysfunction, highlighting limitations of existing studies and outlining future research directions.
Background The primary challenge for hemodialysis (HD) patients using permanent tunneled cuffed catheters is to prevent catheter-related bloodstream infections. This study assessed the effectiveness of sodium bicarbonate in preventing catheter-related bloodstream infections and compared its efficacy to antibiotic-containing locks. Design, materials, and methods We conducted a prospective single-center, open-label, cohort study over 30 months with the aim to compare three cohorts: cohort I employed 8.4% sodium bicarbonate solution lock, cohort II employed 0.5 mg/ml gentamicin/acid citrate dextrose solution lock, and cohort III employed unfractionated conventional heparin 5000 U/ml solution lock. The primary endpoint was the first episode of catheter-related bloodstream infection, while the secondary endpoint was catheter loss due to catheter-related bloodstream infection. Results This study involved 204 HD patients with permanent tunneled cuffed central venous catheters (CVCs). A total of 58 cases of catheter-related bloodstream infection were documented. In the sodium bicarbonate-lock cohort, infection occurred in 17.24%, in the gentamicin/acid citrate-lock cohort in 36.21%, and in the heparin-lock cohort in 46.55%. Patients with sodium bicarbonate and gentamicin/acid citrate locks exhibited a statistically significant lower risk of developing infections (0.4/1000 catheter days and 0.7/1000 catheter days, respectively) compared to patients with heparin-lock (1.4/1000 catheter days). Patients with heparin lock faced a higher risk of losing a catheter due to infection compared to those with gentamicin/acid citrate lock and sodium bicarbonate-lock (Hazard Ratio (HR) = 1.26, 95% Confidence Interval (CI) [1.09–1.46], P = 0.001) and (HR = 1.10, 95% CI [1.01–1.19], P = 0.024). Conclusion The sodium bicarbonate locking solution demonstrated an infection-free catheter survival comparable to that of the gentamicin citrate solution and significantly decreased catheter-related bloodstream infection compared to heparin locks. Graphical abstract
Background: This systematic review and meta-analysis aimed to evaluate antimicrobial resistance patterns among selected Gram-negative bacterial isolates recovered from tracheal aspirate cultures in Türkiye. Methods: The systematic review was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Electronic databases were systematically searched to identify eligible studies reporting antimicrobial resistance patterns among selected Gram-negative bacterial isolates from tracheal aspirate cultures in Türkiye. Random-effects meta-analyses of study-level resistance proportions were performed using the number of resistant and tested isolates reported by each study. Between-study heterogeneity was assessed using Cochran’s Q test and the I2 statistic. Sensitivity analyses and exploratory univariable meta-regression analyses were also performed. Results: Eighteen studies comprising 5436 isolates belonging to five selected Gram-negative bacterial groups recovered from tracheal aspirate cultures were included. The pooled meropenem resistance rates were 93.21% for A. baumannii, 37.7% for P. aeruginosa, 29.3% for K. pneumoniae, and 4.3% for E. coli. Pseudomonas aeruginosa showed a higher pooled meropenem resistance estimate than K. pneumoniae, while both species exhibited substantial resistance to several other commonly used antimicrobial agents. Exploratory meta-regression indicated an increase in meropenem resistance across more recent study periods for K. pneumoniae, whereas no significant temporal trend was observed for A. baumannii or P. aeruginosa. Conclusions: Multidrug-resistant Gram-negative bacteria continue to represent a major problem in tracheal aspirate cultures in Türkiye. In particular, the high prevalence of carbapenem resistance in A. baumannii highlights the need for continuous national surveillance, standardized microbiological methods, strengthened antimicrobial stewardship, and effective infection prevention and control measures.
Bloodstream infection (BSI) is a critical global health concern, frequently leading to sepsis and carrying a high mortality rate directly proportional to delays in appropriate antimicrobial treatment. While conventional blood culture (BC) remains the microbiological gold standard, its protracted turnaround time (TAT) — often requiring 24 to 48 hours for organism identification (ID) and definitive antimicrobial susceptibility testing (AST) — necessitates broad-spectrum empirical therapy, contributing to antibiotic resistance. Recent advancements in clinical microbiology have focused on expediting this diagnostic process. Key culture-based enhancements include Matrix-Assisted Laser Desorption/Ionization-Time of Flight Mass Spectrometry (MALDI-TOF MS) for rapid ID from positive BC bottles, and the implementation of automated phenotypic systems like the Accelerate PhenoTest for faster AST results (within 7 hours). Complementing these are molecular diagnostic platforms, such as multiplex Polymerase Chain Reaction (PCR) panels (e.g., FilmArray, Verigene), which rapidly identify common bacterial and fungal pathogens and crucial antimicrobial resistance determinants (e.g., mecA, vanA/B) directly from positive cultures in under two hours. Further pushing the diagnostic timeline are culture-independent methods, including T2 magnetic resonance and metagenomic Next-Generation Sequencing (mNGS) performed directly on whole blood, which promise comprehensive pathogen detection in less than 8 hours, even in culture-negative sepsis cases. The integration of these rapid diagnostic technologies into laboratory workflows is vital for implementing effective antimicrobial stewardship programs. By providing earlier, actionable results, these methods enable targeted therapy de-escalation, ultimately leading to improved patient prognosis and a more effective public health response to multidrug-resistant organisms.